Europe leads the world in quality of care and patient safety, yet delivering truly personalized treatments remains a challenge. Stringent data rules, complex validation and reimbursement processes demand innovation that moves carefully but keeps pace with technology. This track explores how life sciences organizations can accelerate innovation while ensuring compliance. From navigating EU data regulations and redesigning validation for tailored therapies to leveraging AI discovery tools, microfluidics and digital platforms, you’ll see how regulatory constraints can become drivers of responsible, patient-centred innovation. Check out the presentations from the Innovation Day of 2024 on:
- The light microscope: An evolving tool for advancing cancer therapy
By Didier Beghuin, Business Line Officer of Life Sciences at Lambda-X Verhaert High-Tech - Accelerating data validation with digital platforms
By Margo Billen, Customer Success Manager at Verhaert Product Innovation and Niko De Bruyne, AI Engineer at Verhaert Digital Innovation - Scaling innovation from within: Baxter’s acceleration program
By Wouter Hendrickx, Customer Success Manager at Verhaert Strategic Innovation
View the presentation